Medicine and Dentistry
Acute Graft Rejection
32%
Acute Pancreatitis
18%
Allograft
29%
Antibody
16%
Biopsy Technique
27%
Bladder
9%
Body Mass Index
9%
C-Peptide
17%
Cholangiocarcinoma
10%
Cyclosporine
14%
Delayed Graft Function
10%
Diabetes
26%
Diabetes Mellitus
12%
Eculizumab
10%
Graft Failure
30%
Graft Rejection
14%
Graft Survival
32%
Hepatocellular Carcinoma
14%
Immunosuppressive Drug
11%
Immunosuppressive Treatment
43%
Infection
16%
Insulin Dependent Diabetes Mellitus
15%
Islet Transplantation
15%
Kidney Allograft
20%
Kidney Allograft Rejection
12%
Kidney Function
16%
Kidney Graft
100%
Kidney Pancreas Transplantation
35%
Kidney Transplantation
70%
Liver Graft
21%
Liver Transplantation
35%
Living Donor
30%
Mycophenolate Mofetil
15%
Neoplasm
11%
Organ Transplantation
12%
Osteocalcin
10%
Overall Survival
10%
Pancreas Transplantation
71%
Pancreatic Islet
14%
Patient Referral
9%
Pediatrics
12%
Placebo
11%
Prednisone
11%
Rapamycin
18%
Survival Rate
9%
Tacrolimus
30%
Thymocyte Antibody
21%
Transplantation
97%
Tumor Necrosis Factor
14%
Viremia
11%
Immunology and Microbiology
Acute Graft Rejection
36%
Acute Pancreatitis
21%
Adoptive Immunity
5%
Allograft
31%
Anti-Lymphocyte Globulin
6%
Anti-Thymocyte Globulin
27%
Antibody
17%
Antibody Response
7%
Azathioprine
5%
B Cell
11%
BK Virus
8%
Ciclosporin
17%
Creatinine Blood Level
12%
Cytomegalovirus
7%
Cytomegalovirus Infection
7%
Erythropoietin
5%
Granzyme B
9%
HLA Antibody
6%
Human Leukocyte Antigen
12%
Immunosuppression
34%
Immunosuppressive Drug
12%
Insulin
10%
Intercellular Adhesion Molecule 1
7%
Intravenous Immunoglobulin
8%
Isatuximab
6%
Kidney Allograft Rejection
7%
Kidney Function
9%
Kidney Graft Rejection
5%
Kidney Transplantation
62%
Lipoprotein
5%
Mycophenolate Mofetil
13%
Pancreas
43%
Pancreas Transplantation
47%
Pancreatitis
13%
Panel Reactive Antibody
8%
Peptides
12%
Perforin
6%
Prednisone
9%
Sensitization
6%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Sirolimus
5%
Solid Organ Transplantation
8%
Survival Rate
6%
T Cell
14%
Tacrolimus
24%
Transplant Rejection
12%
Tumor Necrosis Factor
11%
Upregulation
6%
Viral Disease
5%
Viremia
9%
Keyphrases
Acute Pancreatitis
6%
Acute Rejection
13%
Acute Renal Allograft Rejection
5%
African American
5%
Antibody Induction
6%
BK Viremia
7%
Corticosteroid Withdrawal
7%
Cross-sectional Evaluation
5%
Deceased Donor
7%
Enteric Drainage
14%
Graft Loss
8%
Granzyme B
5%
Human Pancreatic Islets
5%
Immunosuppression
13%
Induction Therapy
5%
Isatuximab
5%
Islet
7%
Kidney
7%
Kidney Transplant
15%
Kidney Transplant Recipients
14%
Kidney Transplantation
8%
Liver Transplantation
16%
Living Donor
5%
Living Donor Kidney Transplantation
11%
Mycophenolate Mofetil
5%
Pancreas
7%
Pancreas Transplant
11%
Pancreas Transplantation
12%
Pancreas-kidney Transplantation
9%
Pretransplant
9%
Prospective Randomized Trial
6%
Quality of Life
5%
Retransplantation
5%
Simultaneous Kidney-pancreas Transplantation
7%
Single Center
6%
Single Donor
5%
Single-center Experience
8%
Sirolimus
10%
Solid Organ Transplantation
6%
Sorafenib
5%
Tacrolimus
8%
Transplant Recipients
5%
Transplantation
10%
Ultrasonography Screening
5%
Undercarboxylated Osteocalcin
5%
University of Tennessee
5%